Nitroglycerin mediated dilation evaluated by ultrasound is associated with sTWEAK in hemodialysis patients.

Download Full Article

(292 KB, PDF file)

Nitroglycerin mediated dilation evaluated by ultrasound is associated with sTWEAK in hemodialysis patients.

Crina Claudia Rusu, Liviu Ghervan, Simona Racasan, Ina Kacsa, Diana Moldovan, Alina Potra, Cosmina Bondor, Florin Anton, Ioan Mihai Patiu, Mirela Gherman Caprioara

Abstract

Aims: The main cause of death in hemodialysis (HD) patients is cardiovascular disease. Ultrasound assessment of the bra- chial artery dysfunction is easily achievable and can non-invasively detect atherosclerosis in various stages. In HD patients the cardiovascular risk pro le is different and the determinants of brachial arterial function can be distinct comparing with general population. The aim of the study is to assess the determinants of arterial brachial function ( ow-mediated and nitroglycerin- mediated dilation) evaluated by ultrasound in HD patients and their relation with tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) described as atherosclerotic marker in chronic kidney disease patients. Material and methods: We conducted a cross-sectional observational study on 54 hemodialysis patients. We recorded clinical and biological data and we measured sTWEAK serum levels by ELISA. We evaluated the arterial brachial function by measurement of ow-mediated and nitroglycerin-mediated dilation, using B mode ultrasound. Results: The determinants of ow-mediated dilation were: Kt/V (r=0.47, p<0.001), LDL-cholesterol (r=0.29, p=0.04), and total cholesterol (r=0.31, p=0.02). Flow-mediated dilation correlat- ed with nitroglycerin-mediated dilation (r=0.70, p<0.001). In multivariate analysis kt/V was the only signi cant predictor for ow-mediated dilation (p=0.04). Nitroglycerin-mediated dilation correlates with sTWEAK (r=-0.30, p=0.03), systolic blood pressure (r=-0.28, p=0.04) and pulse pressure (r=-0.31, p=0.02). In multivariate analysis sTWEAK was the only signi cant predictor for nitroglycerin-mediated dilation (p=0.04). Conclusions: The main determinant of nitroglycerin-mediated dilation was sTWEAK. In addition, decreased nitroglycerin-mediated dilation was associated with higher systolic blood pressure and pulse pressure. The main determinant of FMD was Kt/V. Increased ow-mediated dilation was associated with better dialysis ef ciency and high total cholesterol and LDL-cholesterol.

Keywords